In this latest rapid-reference memory aid, Helen O’Neil summarises the dosing, contraindications, and adverse events of drugs for painful neuropathy, along with treatment pathways and advice on switching from gabapentin to pregabalin. Readers are directed to the PDF version of the article.
UK Medicines Information (2017) Q&A 408.1: How do you switch between pregabalin and gabapentin for neuropathic pain, and vice versa? https://bit.ly/3ZS4aMC
Ziegler D, Tesfaye S, Spallone V et al (2022) Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations. Diabetes Res Clin Pract 186: 109063
Sign up to all DiabetesontheNet journals
Journals
Sign up to all DiabetesontheNet journals
By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.
Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.
We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.
SGLT2 inhibitors show greater cardiovascular effects in older versus young people, whilst GLP-1 RAs are more effective in younger people.
1 May 2025